Beat Card: Q4 revenue $9,807M (organic +6.6%, +90bp vs. implied guidance) and non-GAAP EPS $1.55 (beat midpoint of guidance); full-year organic +5.8% is the highest growth rate in 10 years; FY27 beat ...
Medtronic Receives FDA Clearance for Nellcor (TM) Pulse Oximetry System With Nell-EQ (TM) Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse Patients and Conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results